Loading
Latest filing published 23 Apr 2019 for Insys Therapeutics, Inc..
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Rohit Vishnoi discloses dealings in Insys Therapeutics, Inc. to SEC (Form 4). We count 6 filings; the first trade dates from 1 June 2017 and the latest from 4 March 2019.
Every open-market trade on record is a purchase: 1 purchase worth €50k, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 5 share grants.
Most recently, on 23 April 2019, the filings show a share grant in Insys Therapeutics, Inc. The last purchase on record was published on 2 June 2017, which is 3,431 days ago. The median gap between a trade and its publication by SEC (Form 4) is 48 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations